China SXT Pharmaceuticals, Inc.
SXTC
$2.29
$0.7144.94%
NASDAQ
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.00% | 53.37% | 0.00% | 5.28% | 0.00% |
Total Receivables | 0.00% | 19.62% | 0.00% | 4.79% | 0.00% |
Inventory | 0.00% | 96.17% | 0.00% | 39.31% | 0.00% |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | 3,966.18% | 0.00% | -95.86% | 0.00% |
Total Current Assets | 0.00% | 54.48% | 0.00% | 5.47% | 0.00% |
|
|||||
Total Current Assets | 0.00% | 54.48% | 0.00% | 5.47% | 0.00% |
Net Property, Plant & Equipment | 0.00% | -21.52% | 0.00% | -47.23% | 0.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 0.00% | -16.75% | 0.00% | -15.11% | 0.00% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 2.89% | 0.00% | -- | -- |
Total Assets | 0.00% | 34.03% | 0.00% | 58.54% | 0.00% |
|
|||||
Total Accounts Payable | 0.00% | 29.95% | 0.00% | -2.77% | 0.00% |
Total Accrued Expenses | 0.00% | 8.25% | 0.00% | -23.63% | 0.00% |
Short-term Debt | 0.00% | 187.13% | 0.00% | 4.27% | 0.00% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 0.00% | -50.38% | 0.00% | 4.87% | 0.00% |
Total Finance Division Other Current Liabilities | 0.00% | 2.82% | 0.00% | 3.53% | 0.00% |
Total Other Current Liabilities | 0.00% | 2.82% | 0.00% | 3.53% | 0.00% |
Total Current Liabilities | 0.00% | 75.97% | 0.00% | -3.24% | 0.00% |
|
|||||
Total Current Liabilities | 0.00% | 75.97% | 0.00% | -3.24% | 0.00% |
Long-Term Debt | 0.00% | -1.54% | 0.00% | 9.85% | 0.00% |
Short-term Debt | 0.00% | 187.13% | 0.00% | 4.27% | 0.00% |
Capital Leases | 0.00% | 2.93% | 0.00% | -13.37% | 0.00% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 0.00% | 73.57% | 0.00% | -3.31% | 0.00% |
|
|||||
Common Stock & APIC | 0.00% | 3.66% | 0.00% | 6.05% | 0.00% |
Retained Earnings | 0.00% | -3.25% | 0.00% | 21.07% | 0.00% |
Treasury Stock & Other | 0.00% | 44.54% | 0.00% | -0.69% | 0.00% |
Total Common Equity | 0.00% | 7.93% | 0.00% | 174.42% | 0.00% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 0.00% | 7.93% | 0.00% | 174.42% | 0.00% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 0.00% | 7.93% | 0.00% | 174.42% | 0.00% |
|